<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00556114</url>
  </required_header>
  <id_info>
    <org_study_id>NIH-LAMMP-2004-3555</org_study_id>
    <nct_id>NCT00556114</nct_id>
  </id_info>
  <brief_title>A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging</brief_title>
  <official_title>A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Growing evidence shows that altered blood flow plays a major role in many vision-threatening
      diseases including glaucoma, diabetic retinopathy, age-related macular degeneration, Central
      Retinal Vein Occlusion, and Branch Retinal Vein Occlusion. Optical coherence tomography, an
      established imaging technique use for eye exam in clinical ophthalmology, provides
      high-resolution cross sectional images of the retina and has increased our ability to
      understand many eye diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optical Coherence Tomography is a non-invasive technique use a broadband light source to
      illuminate the area of study with light in the near infrared spectrum, then obtains static
      images of tissue structure from interference signals of the back-reflected light.

      Optical Coherence Tomography a non-contact, non-invasive means of documenting both tissue
      structure and blood flow changes in ocular disease and can provide high resolution
      cross-sectional images of tissue structure, direct visualization of blood flow in blood
      vessels of the eye.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Medical exam tool</measure>
    <time_frame>24 hours</time_frame>
    <description>Optical Coherence Tomography imaging technique of the retina and ability to diagnose and manage many eye diseases</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">23</enrollment>
  <condition>Glaucoma</condition>
  <condition>Diabetic Retinopathy</condition>
  <condition>Age-Related Macular Degeneration</condition>
  <condition>Central Retinal Vein Occlusion</condition>
  <condition>Branch Retinal Vein Occlusion</condition>
  <arm_group>
    <arm_group_label>Optical Coherence Tomography</arm_group_label>
    <description>Optical Coherence Tomography</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>Optical Coherence Tomography</description>
    <arm_group_label>Optical Coherence Tomography</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic and community sample.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult 18 years and older with normal eye, or has been diagnosed with eye disease.

        Exclusion Criteria:

          -  Less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baruch D Kuppermann,, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthamology, University of California,Irvine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhongping Chen, Ph,D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute University of California Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute, University of California,Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>02612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2007</study_first_submitted>
  <study_first_submitted_qc>November 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2007</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Baruch D. Kuppermann, M.D., Ph.D.,Professor Department of Ophthalmology and Biomedical Engineering</investigator_title>
  </responsible_party>
  <keyword>eye exam</keyword>
  <keyword>Retina</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Retinal Vein Occlusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

